Oxford-astrazeneca
-
{
- All
- News
- Videos
-
Next Pandemic Could Be More "Lethal" Than Covid, Vaccine Creator Warns
Future pandemics could be more lethal than COVID-19 so the lessons learned from the outbreak must not be squandered and the world should ensure it is prepared for the next viral onslaught, one of the creators of the Oxford-AstraZeneca vaccine said.
-
Mix-And-Match Vaccines Highly Effective Against COVID-19: Lancet Study
People who received a first dose of the Oxford-AstraZeneca COVID-19 vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses of the AstraZeneca preventive, according to a nationwide study.
-
"Not Many Places Left For Covid To Evade Immunity": UK Vaccine Creator
There aren't many places left for the COVID-19 virus to mutate and evade immunity as it will only get weaker with time, said the creator of the Oxford-AstraZeneca vaccine, the most widely distributed jab in the world.
-
"India Still Has Some Covid": UK On Stricter Quarantine Rules For Indians
Although it is the same as the Oxford-AstraZeneca vaccine used in the UK's immunisation programme, Covishield wasn't approved until now. But the problem, the British envoy in India said, is India isn't on the 'green list' as Covid cases remain here.
-
AstraZeneca COVID-19 Vaccine Linked With Small Risk Of Low Blood Platelets: Study
The Oxford-AstraZeneca vaccine, also known as Covishield, may be associated with a very small risk of developing a blood condition characterised by low platelet counts, according to a nationwide study in the UK.
-
UK Advises Under-40s Get Alternative To AstraZeneca Covid Vaccine
The scientific committee overseeing Britain's coronavirus vaccination programme on Friday recommended that under-40s are offered an alternative to the Oxford-AstraZeneca Covid jab.
-
Slightly Increased Blood Clot Rates After AstraZeneca Shot: Study
A large study in Denmark and Norway has found slightly increased rates of vein blood clots, including in the brain, among adults who had received their first dose of the Oxford-AstraZeneca COVID-19 vaccine.
-
Punjab To Order 30 Lakh Doses Of Covishield As Vaccination Drive Widens
Punjab Chief Minister Amarinder Singh on Sunday directed the health department to order 30 lakh doses of Oxford-AstraZeneca COVID-19 vaccine, Covishield, from the Serum Institute of India for vaccination of the 18-45 age group.
-
7 Deaths Among UK AstraZeneca Jab Recipients After Blood Clots: Regulator
The UK medical regulator said Saturday that out of 30 people who suffered rare blood clots after receiving the Oxford-AstraZeneca vaccine, seven have died.
-
7 Deaths In UK From Blood Clots Among Millions Who Got AstraZeneca Shot
The UK medical regulator said Saturday that out of 30 people who suffered rare blood clots after receiving the Oxford-AstraZeneca vaccine, seven have died.
-
Next Pandemic Could Be More "Lethal" Than Covid, Vaccine Creator Warns
Future pandemics could be more lethal than COVID-19 so the lessons learned from the outbreak must not be squandered and the world should ensure it is prepared for the next viral onslaught, one of the creators of the Oxford-AstraZeneca vaccine said.
-
Mix-And-Match Vaccines Highly Effective Against COVID-19: Lancet Study
People who received a first dose of the Oxford-AstraZeneca COVID-19 vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses of the AstraZeneca preventive, according to a nationwide study.
-
"Not Many Places Left For Covid To Evade Immunity": UK Vaccine Creator
There aren't many places left for the COVID-19 virus to mutate and evade immunity as it will only get weaker with time, said the creator of the Oxford-AstraZeneca vaccine, the most widely distributed jab in the world.
-
"India Still Has Some Covid": UK On Stricter Quarantine Rules For Indians
Although it is the same as the Oxford-AstraZeneca vaccine used in the UK's immunisation programme, Covishield wasn't approved until now. But the problem, the British envoy in India said, is India isn't on the 'green list' as Covid cases remain here.
-
AstraZeneca COVID-19 Vaccine Linked With Small Risk Of Low Blood Platelets: Study
The Oxford-AstraZeneca vaccine, also known as Covishield, may be associated with a very small risk of developing a blood condition characterised by low platelet counts, according to a nationwide study in the UK.
-
UK Advises Under-40s Get Alternative To AstraZeneca Covid Vaccine
The scientific committee overseeing Britain's coronavirus vaccination programme on Friday recommended that under-40s are offered an alternative to the Oxford-AstraZeneca Covid jab.
-
Slightly Increased Blood Clot Rates After AstraZeneca Shot: Study
A large study in Denmark and Norway has found slightly increased rates of vein blood clots, including in the brain, among adults who had received their first dose of the Oxford-AstraZeneca COVID-19 vaccine.
-
Punjab To Order 30 Lakh Doses Of Covishield As Vaccination Drive Widens
Punjab Chief Minister Amarinder Singh on Sunday directed the health department to order 30 lakh doses of Oxford-AstraZeneca COVID-19 vaccine, Covishield, from the Serum Institute of India for vaccination of the 18-45 age group.
-
7 Deaths Among UK AstraZeneca Jab Recipients After Blood Clots: Regulator
The UK medical regulator said Saturday that out of 30 people who suffered rare blood clots after receiving the Oxford-AstraZeneca vaccine, seven have died.
-
7 Deaths In UK From Blood Clots Among Millions Who Got AstraZeneca Shot
The UK medical regulator said Saturday that out of 30 people who suffered rare blood clots after receiving the Oxford-AstraZeneca vaccine, seven have died.
